TSC
ABVX

Two Seas Capital’s Abivax ABVX Stock Holding History

Two Seas Capital’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35.5M Buy
+266,400
New +$30.2M 0.7% 25

Other funds holding ABVX

HI
Helikon Investments London, United Kingdom $3.35B AUM 55.08% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
NNPTE
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne Warszawa, Poland $1.83B AUM 331.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $646M AUM 291.07% 1-Year Est. Return
WSL
Western Standard LLC Los Angeles, California $295M AUM 40.98% 1-Year Est. Return

Two Seas Capital's ABVX Position: Q2 2026 in Review

Two Seas Capital opened a new position in Abivax (ABVX) in Q2 2026: 244,590 shares worth $32.6M. The stake represents 0.65% of the portfolio and ranks #27 among its holdings.

148 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • Two Seas Capital held 244,590 shares of Abivax worth $32.6M as of Q2 2026.
  • Abivax was a new Two Seas Capital position in Q2 2026.
  • Abivax made up 0.65% of Two Seas Capital's portfolio in Q2 2026, its #27 holding.
  • 148 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on Two Seas Capital's 13F filing for Q2 2026, filed 12 Aug 2026.